{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:33:19Z","timestamp":1763044399574,"version":"3.45.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,13]]},"DOI":"10.7759\/cureus.96760","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:29:06Z","timestamp":1763044146000},"source":"Crossref","is-referenced-by-count":0,"title":["Standing Still: A Case of Stiff Person Syndrome and Common Variable Immunodeficiency"],"prefix":"10.7759","author":[{"given":"Vicken","family":"Khazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"McClain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M","family":"Szema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23234","article-title":"Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes","volume":"45","author":"Rakocevic G","year":"2012","unstructured":"Rakocevic G, Floeter MK. Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes. Muscle Nerve. 2012, 45:623-34. 10.1002\/mus.23234","journal-title":"Muscle Nerve"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2012.09.005","article-title":"Stiff person syndrome","volume":"31","author":"Ciccotto G","year":"2013","unstructured":"Ciccotto G, Blaya M, Kelley RE. Stiff person syndrome. Neurol Clin. 2013, 31:319-28. 10.1016\/j.ncl.2012.09.005","journal-title":"Neurol Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2013.845527","article-title":"Immunology of stiff person syndrome and other GAD-associated neurological disorders","volume":"9","author":"Alexopoulos H","year":"2013","unstructured":"Alexopoulos H, Dalakas MC. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Rev Clin Immunol. 2013, 9:1043-53. 10.1586\/1744666X.2013.845527","journal-title":"Expert Rev Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.06.021","article-title":"SPS: understanding the complexity","volume":"404","author":"El-Abassi R","year":"2019","unstructured":"El-Abassi R, Soliman MY, Villemarette-Pittman N, England JD. SPS: understanding the complexity. J Neurol Sci. 2019, 404:137-49. 10.1016\/j.jns.2019.06.021","journal-title":"J Neurol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211003486","article-title":"GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions","volume":"14","author":"Tsiortou P","year":"2021","unstructured":"Tsiortou P, Alexopoulos H, Dalakas MC. GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions. Ther Adv Neurol Disord. 2021, 14:17562864211003486. 10.1177\/17562864211003486","journal-title":"Ther Adv Neurol Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2011-000071","article-title":"Stiff person syndrome","volume":"11","author":"Hadavi S","year":"2011","unstructured":"Hadavi S, Noyce AJ, Leslie RD, Giovannoni G. Stiff person syndrome. Pract Neurol. 2011, 11:272-82. 10.1136\/practneurol-2011-000071","journal-title":"Pract Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11995","article-title":"Stiff-person syndrome: a treatment update and new directions","volume":"12","author":"Ortiz JF","year":"2020","unstructured":"Ortiz JF, Ghani MR, Morillo Cox \u00c1, Tambo W, Bashir F, Wirth M, Moya G. Stiff-person syndrome: a treatment update and new directions. Cureus. 2020, 12:e11995. 10.7759\/cureus.11995","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.051144","article-title":"Treatment of stiff person syndrome with rituximab","volume":"76","author":"Baker MR","year":"2005","unstructured":"Baker MR, Das M, Isaacs J, Fawcett PR, Bates D. Treatment of stiff person syndrome with rituximab. J Neurol Neurosurg Psychiatry. 2005, 76:999-1001. 10.1136\/jnnp.2004.051144","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles C","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999, 92:34-48. 10.1006\/clim.1999.4725","journal-title":"Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla FA","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, et al.. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016, 4:38-59. 10.1016\/j.jaip.2015.07.025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200109","article-title":"Therapies in stiff-person syndrome: advances and future prospects based on disease pathophysiology","volume":"10","author":"Dalakas MC","year":"2023","unstructured":"Dalakas MC. Therapies in stiff-person syndrome: advances and future prospects based on disease pathophysiology. Neurol Neuroimmunol Neuroinflamm. 2023, 10:e200109. 10.1212\/NXI.0000000000200109","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103701","article-title":"Neurological syndromes associated with anti-GAD antibodies","volume":"21","author":"Dade M","year":"2020","unstructured":"Dade M, Berzero G, Izquierdo C, et al.. Neurological syndromes associated with anti-GAD antibodies. Int J Mol Sci. 2020, 21:3701. 10.3390\/ijms21103701","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for stiff-person syndrome","volume":"345","author":"Dalakas MC","year":"2001","unstructured":"Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med. 2001, 345:1870-6. 10.1056\/NEJMoa01167","journal-title":"N Engl J Med"},{"key":"ref14","article-title":"Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency","volume":"21","author":"Baris S","year":"2011","unstructured":"Baris S, Ercan H, Cagan HH, Ozen A, Karakoc-Aydiner E, Ozdemir C, Bahceciler NN. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2011, 21:514-21.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13157-2","article-title":"Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review","volume":"272","author":"Pignolo A","year":"2025","unstructured":"Pignolo A, Vinciguerra C, Monastero R, et al.. Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review. J Neurol. 2025, 272:417. 10.1007\/s00415-025-13157-2","journal-title":"J Neurol"},{"key":"ref16","article-title":"Differentiating characteristics and evaluating intravenous and subcutaneous immunoglobulin","volume":"25","author":"Ness S","year":"2019","unstructured":"Ness S. Differentiating characteristics and evaluating intravenous and subcutaneous immunoglobulin. Am J Manag Care. 2019, 25:S98-104.","journal-title":"Am J Manag Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.01.025","article-title":"Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a\u00a0work group report of the AAAAI primary immunodeficiency and altered immune response committees","volume":"149","author":"Otani IM","year":"2022","unstructured":"Otani IM, Lehman HK, Jongco AM, et al.. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a\u00a0work group report of the AAAAI primary immunodeficiency and altered immune response committees. J Allergy Clin Immunol. 2022, 149:1525-60. 10.1016\/j.jaci.2022.01.025","journal-title":"J Allergy Clin Immunol"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247717","article-title":"Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies","volume":"16","author":"Cinetto F","year":"2021","unstructured":"Cinetto F, Neri R, Vianello F, et al.. Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies. PLoS One. 2021, 16:e0247717.","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12573","article-title":"Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: the ADVANCE-CIDP 1 randomized controlled trial","volume":"28","author":"Bril V","year":"2023","unstructured":"Bril V, Hadden RD, Brannagan TH 3rd, et al.. Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: the ADVANCE-CIDP 1 randomized controlled trial. J Peripher Nerv Syst. 2023, 28:436-49. 10.1111\/jns.12573","journal-title":"J Peripher Nerv Syst"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2025.05.016","article-title":"Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for inflammatory myositis: a multicenter retrospective real-world observational study","volume":"138","author":"Palermo A","year":"2025","unstructured":"Palermo A, Biancalana E, Bettiol A, et al.. Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for inflammatory myositis: a multicenter retrospective real-world observational study. Eur J Intern Med. 2025, 138:91-5. 10.1016\/j.ejim.2025.05.016","journal-title":"Eur J Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S31136","article-title":"Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency","volume":"2","author":"Jolles S","year":"2013","unstructured":"Jolles S. Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency. Immunotargets Ther. 2013, 2:125-33. 10.2147\/ITT.S31136","journal-title":"Immunotargets Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/429321-standing-still-a-case-of-stiff-person-syndrome-and-common-variable-immunodeficiency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:29:08Z","timestamp":1763044148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/429321-standing-still-a-case-of-stiff-person-syndrome-and-common-variable-immunodeficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.96760","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}